2024 Q3 Form 10-Q Financial Statement

#000095017024117409 Filed on October 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $33.16M
YoY Change 1.36%
% of Gross Profit
Research & Development $96.99M
YoY Change 10.03%
% of Gross Profit
Depreciation & Amortization $14.94M
YoY Change 28.27%
% of Gross Profit
Operating Expenses $130.2M
YoY Change 7.68%
Operating Profit -$130.2M
YoY Change 7.68%
Interest Expense $10.80M
YoY Change 1720.74%
% of Operating Profit
Other Income/Expense, Net $10.46M
YoY Change 1.86%
Pretax Income -$119.7M
YoY Change 8.23%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$119.6M
YoY Change 8.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.23
Diluted Earnings Per Share -$0.23
COMMON SHARES
Basic Shares Outstanding 509.0M
Diluted Shares Outstanding 509.0M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.5M
YoY Change -44.9%
Cash & Equivalents $174.7M
Short-Term Investments $40.80M
Other Short-Term Assets $12.70M
YoY Change 25.74%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $853.7M
YoY Change -24.95%
LONG-TERM ASSETS
Property, Plant & Equipment $317.5M
YoY Change -1.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.08M
YoY Change 7.51%
Total Long-Term Assets $418.3M
YoY Change -2.32%
TOTAL ASSETS
Total Short-Term Assets $853.7M
Total Long-Term Assets $418.3M
Total Assets $1.272B
YoY Change -18.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.635M
YoY Change 0.18%
Accrued Expenses $19.67M
YoY Change 96.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $3.149M
YoY Change 12.46%
Total Short-Term Liabilities $60.69M
YoY Change 31.1%
LONG-TERM LIABILITIES
Long-Term Debt $32.71M
YoY Change -8.89%
Other Long-Term Liabilities $13.58M
YoY Change 15.92%
Total Long-Term Liabilities $13.58M
YoY Change 15.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.69M
Total Long-Term Liabilities $13.58M
Total Liabilities $161.4M
YoY Change 5.63%
SHAREHOLDERS EQUITY
Retained Earnings -$3.244B
YoY Change 17.22%
Common Stock $4.354B
YoY Change 4.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.111B
YoY Change
Total Liabilities & Shareholders Equity $1.272B
YoY Change -18.76%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$119.6M
YoY Change 8.1%
Depreciation, Depletion And Amortization $14.94M
YoY Change 28.27%
Cash From Operating Activities -$92.80M
YoY Change 48.34%
INVESTING ACTIVITIES
Capital Expenditures $17.93M
YoY Change -0.3%
Acquisitions
YoY Change
Other Investing Activities $84.06M
YoY Change -144.0%
Cash From Investing Activities $66.13M
YoY Change -131.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.987M
YoY Change -98.28%
NET CHANGE
Cash From Operating Activities -92.80M
Cash From Investing Activities 66.13M
Cash From Financing Activities 4.987M
Net Change In Cash -21.68M
YoY Change -217.14%
FREE CASH FLOW
Cash From Operating Activities -$92.80M
Capital Expenditures $17.93M
Free Cash Flow -$110.7M
YoY Change 37.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001811414
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39345
dei Entity Registrant Name
EntityRegistrantName
QUANTUMSCAPE CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0796578
dei Entity Address Address Line1
EntityAddressAddressLine1
1730 Technology Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95110
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
452-2000
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
QS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
174705000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142524000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
666309000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
928284000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12700000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12709000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
853714000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1083517000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
317509000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313164000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
22985000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
25140000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52689000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55863000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25080000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24294000
CY2024Q3 us-gaap Assets
Assets
1271977000
CY2023Q4 us-gaap Assets
Assets
1501978000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9635000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12959000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19674000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10180000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22848000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26043000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5387000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5006000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3149000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2907000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
60693000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57095000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54374000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57622000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32710000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
35098000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13575000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11986000
CY2024Q3 us-gaap Liabilities
Liabilities
161352000
CY2023Q4 us-gaap Liabilities
Liabilities
161801000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1770000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
51000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4353487000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4221892000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
939000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2877000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3243852000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2880657000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1110625000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1338407000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1271977000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1501978000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96994000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88154000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
278587000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
251548000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33164000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32716000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117929000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
102842000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
130158000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
120870000
us-gaap Operating Expenses
OperatingExpenses
396516000
us-gaap Operating Expenses
OperatingExpenses
354390000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-130158000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-120870000
us-gaap Operating Income Loss
OperatingIncomeLoss
-396516000
us-gaap Operating Income Loss
OperatingIncomeLoss
-354390000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
550000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
593000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1684000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1795000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
11347000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10479000
us-gaap Investment Income Interest
InvestmentIncomeInterest
35428000
us-gaap Investment Income Interest
InvestmentIncomeInterest
24075000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-338000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
382000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-508000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
370000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10459000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10268000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33236000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22650000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-119699000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-110602000
us-gaap Profit Loss
ProfitLoss
-363280000
us-gaap Profit Loss
ProfitLoss
-331740000
CY2024Q3 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2023Q3 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-127000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
15000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-85000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
45000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-119572000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-110617000
us-gaap Net Income Loss
NetIncomeLoss
-363195000
us-gaap Net Income Loss
NetIncomeLoss
-331785000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-119699000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-110602000
us-gaap Profit Loss
ProfitLoss
-363280000
us-gaap Profit Loss
ProfitLoss
-331740000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1458000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3392000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3816000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11550000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-118241000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-107210000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-359464000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-320190000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-127000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
15000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-85000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
45000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118114000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107225000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-359379000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-320235000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
508957000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
508957000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
471752000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
471752000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
502136000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
502136000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
452503000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
452503000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1812000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1180269000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7398000
CY2024Q3 qs Shares Issued Upon Vesting Of Restricted Stock Units Value
SharesIssuedUponVestingOfRestrictedStockUnitsValue
2769000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38303000
CY2024Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-127000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-119572000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1458000
CY2024Q3 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1685000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1110625000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1770000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1338407000
qs Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
13968000
qs Shares Issued Upon Vesting Of Restricted Stock Units Value
SharesIssuedUponVestingOfRestrictedStockUnitsValue
23085000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
94544000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-85000
us-gaap Net Income Loss
NetIncomeLoss
-363195000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3816000
us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1685000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1110625000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1734000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1189252000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2297000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38791000
CY2023Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
15000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-110617000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3392000
CY2023Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1749000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1411269000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1317840000
qs Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
9930000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
115580000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
45000
us-gaap Net Income Loss
NetIncomeLoss
-331785000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11550000
CY2023Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1749000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1411269000
us-gaap Profit Loss
ProfitLoss
-363280000
us-gaap Profit Loss
ProfitLoss
-331740000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39795000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31177000
qs Operating And Finance Lease Amortization Of Right Of Use Asset And Non Cash Lease Expense
OperatingAndFinanceLeaseAmortizationOfRightOfUseAssetAndNonCashLeaseExpense
5980000
qs Operating And Finance Lease Amortization Of Right Of Use Asset And Non Cash Lease Expense
OperatingAndFinanceLeaseAmortizationOfRightOfUseAssetAndNonCashLeaseExpense
5825000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
23124000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10855000
us-gaap Share Based Compensation
ShareBasedCompensation
110471000
us-gaap Share Based Compensation
ShareBasedCompensation
128373000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1533000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
6342000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-186000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-474000
qs Increase Decrease In Prepaid Deferred Expense And Other Current Assets And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssetsAndOtherAssets
777000
qs Increase Decrease In Prepaid Deferred Expense And Other Current Assets And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssetsAndOtherAssets
3985000
qs Increase Decrease In Accounts Payable Accrued Liabilities And Accrued Compensation And Benefits
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndAccruedCompensationAndBenefits
15984000
qs Increase Decrease In Accounts Payable Accrued Liabilities And Accrued Compensation And Benefits
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndAccruedCompensationAndBenefits
-5544000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3717000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2270000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1051000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-348000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215898000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-182551000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50969000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70708000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1146587000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
702128000
qs Proceeds From Sales Of Marketable Securities
ProceedsFromSalesOfMarketableSecurities
1245000
qs Proceeds From Sales Of Marketable Securities
ProceedsFromSalesOfMarketableSecurities
1477000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
858921000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
731461000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
237942000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98564000
qs Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan
ProceedsFromExerciseOfStockOptionsAndEmployeeStockPurchasePlan
13968000
qs Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan
ProceedsFromExerciseOfStockOptionsAndEmployeeStockPurchasePlan
9930000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
288431000
qs Principal Payments For Finance Lease
PrincipalPaymentsForFinanceLease
2146000
qs Principal Payments For Finance Lease
PrincipalPaymentsForFinanceLease
1290000
qs Payments For Dissolution Of Joint Venture
PaymentsForDissolutionOfJointVenture
1685000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10137000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
297071000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32181000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15956000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
160572000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252916000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192753000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
268872000
us-gaap Interest Paid Net
InterestPaidNet
1684000
us-gaap Interest Paid Net
InterestPaidNet
1195000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4702000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7289000
qs Common Stock Issuance Costs Accrued But Not Paid
CommonStockIssuanceCostsAccruedButNotPaid
277000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
174705000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250824000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18048000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18048000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192753000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
268872000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. Nature of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Organization</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The original QuantumScape Corporation, now named QuantumScape Battery, Inc. (“Legacy QuantumScape”), a wholly owned subsidiary of the Company (as defined below), was founded in 2010 with the mission to revolutionize energy storage to enable a sustainable future. In 2020, QuantumScape became a publicly traded company (NYSE: QS) through a business combination with a special purpose acquisition company named Kensington Capital Acquisition Corp. (“Kensington”) which changed its name to QuantumScape Corporation upon closing in November 2020 (the “Business Combination”). As a result of the Business Combination, QuantumScape Battery Inc. survived and became a wholly owned subsidiary of QuantumScape Corporation (the “Company”).</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is focused on the development and commercialization of its solid-state lithium-metal batteries. Planned principal operations have not yet commenced. As of September 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company had not derived revenue from its principal business activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock prior to the Business Combination and valuation of awards under the Extraordinary Performance Award Program (the “EPA Program”), among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2018Q3 qs Number Of Operating Agreements Of Joint Venture Parties
NumberOfOperatingAgreementsOfJointVentureParties
2
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents and marketable securities. As of September 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">124.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">115.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of our total cash and cash equivalents and marketable securities, are held in U.S. money market funds, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">617.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">723.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million are invested in U.S. government and agency securities, respectively. The Company seeks to mitigate its credit risk with respect to cash and cash equivalents and marketable securities by making deposits with what we believe to be large, reputable financial institutions and investing in high credit rated shorter-term instruments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18000000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18000000
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
6300000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
6300000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
40800000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
24400000
CY2024Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0
qs Number Of Marketable Securities
NumberOfMarketableSecurities
6
CY2023 qs Number Of Marketable Securities
NumberOfMarketableSecurities
51
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
23678000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
16000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6045000
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
21000
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
29723000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
15000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
45079000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3236000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
212781000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3251000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
257860000
CY2024Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1200000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1500000
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
828891000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
829830000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
1997000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1997000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
830888000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
831827000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
463493000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
420922000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
145984000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
107758000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
317509000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313164000
CY2024Q3 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
14800000
CY2023Q3 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
11200000
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
39300000
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
30000000
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11850000
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
4000000
CY2024Q3 qs Accrued Property And Equipment
AccruedPropertyAndEquipment
1900000
CY2023Q4 qs Accrued Property And Equipment
AccruedPropertyAndEquipment
3203000
CY2024Q3 qs Accrued Facilities Expense
AccruedFacilitiesExpense
1124000
CY2023Q4 qs Accrued Facilities Expense
AccruedFacilitiesExpense
730000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4800000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2247000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19674000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10180000
CY2024Q3 qs Long Term Advance Payments
LongTermAdvancePayments
2515000
CY2023Q4 qs Long Term Advance Payments
LongTermAdvancePayments
2515000
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
11060000
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
9471000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13575000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11986000
qs Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2032
us-gaap Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
The Company did not include renewal options in the calculation of the lease liability and right-of use asset at the lease inception unless the exercise of such options was reasonably certain.
qs Lessee Operating Lease Extension Of Lease Term Month And Year
LesseeOperatingLeaseExtensionOfLeaseTermMonthAndYear
2032-09
qs Lessee Finance Lease Extension Of Lease Term Month And Year
LesseeFinanceLeaseExtensionOfLeaseTermMonthAndYear
2032-09
us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
718000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
718000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2155000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2155000
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
550000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
593000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1684000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1795000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2253000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2253000
us-gaap Operating Lease Cost
OperatingLeaseCost
6745000
us-gaap Operating Lease Cost
OperatingLeaseCost
6795000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
800000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
695000
us-gaap Variable Lease Cost
VariableLeaseCost
2456000
us-gaap Variable Lease Cost
VariableLeaseCost
3065000
CY2024Q3 us-gaap Lease Cost
LeaseCost
4321000
CY2023Q3 us-gaap Lease Cost
LeaseCost
4259000
us-gaap Lease Cost
LeaseCost
13040000
us-gaap Lease Cost
LeaseCost
13810000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1684000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1195000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2146000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1290000
us-gaap Operating Lease Payments
OperatingLeasePayments
6605000
us-gaap Operating Lease Payments
OperatingLeasePayments
5224000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
777000
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0606
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0606
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M6D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0634
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0636
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2229000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsNetOfReimbursementsRemainderOfFiscalYear
1301000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9074000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due Next Twelve Months
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueNextTwelveMonths
5272000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9333000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Two
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearTwo
5417000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9565000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Three
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearThree
5566000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9569000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Four
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFour
5719000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9686000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFive
5876000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
27279000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due After Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueAfterYearFive
16469000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
76735000
CY2024Q3 qs Finance Lease Liability Payments Net Of Reimbursements Due
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDue
45620000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16974000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
9761000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
59761000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
35859000
us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
24500000
us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
47500000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
400000
CY2024Q3 us-gaap Insurance Receivable For Malpractice
InsuranceReceivableForMalpractice
23400000
CY2024Q3 us-gaap Escrow Deposit
EscrowDeposit
47500000
CY2024Q3 us-gaap Insurance Receivable For Malpractice
InsuranceReceivableForMalpractice
23400000
CY2024Q3 qs Litigation Settlement Outstanding Liability Amount
LitigationSettlementOutstandingLiabilityAmount
0
CY2021Q1 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
2
CY2021Q1 qs Number Of Officers And Directors In Shareholder Derivative Suit
NumberOfOfficersAndDirectorsInShareholderDerivativeSuit
11
CY2022Q2 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
4
qs Number Of Additional Shareholder Derivative Actions Filed
NumberOfAdditionalShareholderDerivativeActionsFiled
2
CY2024Q3 qs Securities Class Action Litigation Settlement Amount Accrued For Other Matters
SecuritiesClassActionLitigationSettlementAmountAccruedForOtherMatters
12000000
us-gaap Other Commitments Description
OtherCommitmentsDescription
The Company’s minimum purchase commitments consist of non-cancellable agreements to purchase goods and services, primarily for materials, and licenses and hosting services, entered into in the ordinary course of business.
CY2024Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
955000
CY2024Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
4309000
CY2024Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
2142000
CY2024Q3 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
1418000
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
8824000
CY2024Q3 qs Shares Authorized
SharesAuthorized
1350000000
CY2023Q4 qs Shares Authorized
SharesAuthorized
1350000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holder of each share of Class A Common Stock is entitled to one vote, and the holder of each share of Class B Common Stock is entitled to ten votes.
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42141000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.6
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M23D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9031000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.04
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6621000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.67
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
26489000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
73203000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
22836000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
73203000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
20048000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y5M19D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
72966000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
31300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46300000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y10M24D
CY2024Q3 qs Number Of Identified Business Milestones
NumberOfIdentifiedBusinessMilestones
11
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8400000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43359000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40391000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
110471000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
128373000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-119572000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-110617000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-363195000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-331785000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66769000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73708000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1770000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-85000
qs Dissolution Of Joint Venture In Redeemable Non Controlling Interest
DissolutionOfJointVentureInRedeemableNonControllingInterest
-1685000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
45000
CY2023Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1749000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-117409-index-headers.html Edgar Link pending
0000950170-24-117409-index.html Edgar Link pending
0000950170-24-117409.txt Edgar Link pending
0000950170-24-117409-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
qs-20240930.htm Edgar Link pending
qs-20240930.xsd Edgar Link pending
qs-ex31_1.htm Edgar Link pending
qs-ex31_2.htm Edgar Link pending
qs-ex32_1.htm Edgar Link pending
qs-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
qs-20240930_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending